SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-053652
Filing Date
2018-10-12
Accepted
2018-10-12 16:06:06
Documents
6
Period of Report
2018-10-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv504730_8-k.htm 8-K 27402
2 EXHIBIT 1.1 tv504730_ex1-1.htm EX-1.1 239110
3 EXHIBIT 5.1 tv504730_ex5-1.htm EX-5.1 5963
4 EXHIBIT 99.1 tv504730_ex99-1.htm EX-99.1 9890
5 EXHIBIT 99.2 tv504730_ex99-2.htm EX-99.2 10706
6 GRAPHIC logo.jpg GRAPHIC 8203
  Complete submission text file 0001144204-18-053652.txt   305920
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36860 | Film No.: 181120304
SIC: 2836 Biological Products, (No Diagnostic Substances)